5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.60▼ | 1.60▼ | 1.60▼ | 1.52▲ | 1.48▲ |
MA10 | 1.60▼ | 1.61▼ | 1.57▲ | 1.48▲ | 1.54▲ |
MA20 | 1.61▼ | 1.56▲ | 1.54▲ | 1.47▲ | 1.63▼ |
MA50 | 1.56▲ | 1.50▲ | 1.50▲ | 1.54▲ | 2.29▼ |
MA100 | 1.51▲ | 1.49▲ | 1.48▲ | 1.65▼ | 3.48▼ |
MA200 | 1.49▲ | 1.51▲ | 1.55▲ | 2.10▼ | 9.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | 0.001▲ | 0.008▲ | 0.017▲ | 0.038▲ |
RSI | 49.962▼ | 58.106▲ | 59.298▲ | 57.550▲ | 42.227▼ |
STOCH | 60.290 | 68.454 | 83.333▲ | 54.771 | 19.763▼ |
WILL %R | -63.636 | -30.769 | -30.769 | -31.373 | -76.471▼ |
CCI | -53.296 | 23.662 | 64.629 | 211.236▲ | -45.579 |
MA | $APRE Price Crossed Above MA(50) | Set Alert |
Wednesday, October 15, 2025 05:12 AM
RP2D of 1,100 mg once daily identified in ongoing ABOYA-119 dose-escalation studyFurther ATRN-119 monotherapy enrollment paused with strategic focus on high-value combinationCompany is prioritizing ...
|
Tuesday, October 14, 2025 05:13 AM
Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...
|
Friday, August 22, 2025 08:40 AM
At a glitzy ceremony in AT&T Stadium this week, the newly minted NYSE Texas sent a clear message to competition: The “Y’all Street” marathon has a leader, and it’s only building on its head start. In ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/10/25 | 1.53 | 1.65 | 1.53 | 1.57 | 163,043 |
16/10/25 | 1.54 | 1.5696 | 1.50 | 1.54 | 61,579 |
15/10/25 | 1.51 | 1.57 | 1.48 | 1.49 | 132,252 |
14/10/25 | 1.51 | 1.53 | 1.473 | 1.51 | 55,244 |
13/10/25 | 1.41 | 1.52 | 1.3999 | 1.47 | 92,256 |
10/10/25 | 1.50 | 1.51 | 1.395 | 1.42 | 72,117 |
09/10/25 | 1.45 | 1.53 | 1.44 | 1.477 | 104,709 |
08/10/25 | 1.49 | 1.50 | 1.41 | 1.432 | 58,160 |
07/10/25 | 1.47 | 1.54 | 1.44 | 1.44 | 51,537 |
06/10/25 | 1.53 | 1.55 | 1.48 | 1.485 | 55,441 |
|
|
||||
|
|
||||
|
|